Revision Skincare®, a leader in professional skincare innovation, announces the launch of DermProtect Barrier Defense™, an ...

Revision Skincare®, a leader in professional skincare innovation, announces the launch of DermProtect Barrier Defensetm, an intensive moisturizer that sets a new standard in barrier repair and ...

DALLAS, Jan. 17, 2025 /PRNewswire/ -- Revision Skincare®, a leader in professional skincare innovation, announces the launch of DermProtect Barrier Defense™, an intensive moisturizer that sets ...

This new intensive moisturizer targets the source of dryness and barrier dysfunction, supporting and protecting the ...

Financial writer upgrades RCEL stock to Buy due to growth potential, international expansion, and undervaluation ...

Novant Health is already making strides in 2025 towards its goal to become the largest health care system in the Carolinas.

Novant Health Inc.'s provider acquisitions are part of the Winston-Salem not-for-profit healthcare system's campaign to ...

AVITA's Q4 sales blip was temporary. RECELL GO is still a game-changing technology. Learn why RCEL stock is a Buy.

Results Literature revision detected the absence of papers reporting good ... connective tissue disorders characterised by remarkable joint hypermobility, abnormal skin texture and tissue fragility ...

[29] The ABM Protocol #5, Revision 2008 states, "The healthy newborn can be given directly to the mother for skin-to-skin contact until the first feeding is accomplished. The infant may be dried ...